During the AAN 2021 Virtual Annual Meeting, investigators presented their findings on the safety and efficacy of onasemnogene abeparvovec (formerly AVXS-101) in presymptomatic SMA patients with 3 copies of the survival motor neuron 2 gene.
Brandon May is a freelance medical writer and owner of May Medical Communications, LLC. He holds a BS in Nutrition and Dietetics from the University of Houston. Throughout his career, he has written over 700 medical news articles across several different therapeutic areas. In addition to covering the medical news, Brandon also creates content for continuing medical education providers, hospitals, and pharmaceutical and medical device companies across the globe.